Pharmacy

Pharmacy Formulary and Medical Policy Changes

November 7, 2024
 

Starting January 2025, some drugs will have a formulary drug list change. Find out more on our drug list changes page.

Also, starting January 2025, the following drugs will require a new prior authorization:

Condition Drugs Requiring a New Prior Authorization Preferred Alternatives
Asthma
  • Airsupra (albuterol-budesonide)
  • Brand Albuterol HFA
  • Brand Levalbuterol HFA
  • ProAir Respiclick (albuterol)
  • Ventolin HFA (albuterol)
  • Xopenex HFA (levalbuterol)
  • Generic albuterol HFA
Cancer
  • Avastin (bevacizumab)
  • Mvasi (bevacizumab-awwb)
  • Zirabev (bevacizumab-bvzr)
  • Herceptin (trastuzumab)
  • Herceptin Hylecta (trastuzumab-hyaluronidase-oysk)
  • Kanjinti (trastuzumab-anns)
  • Trazimera (trastuzumab-qyyp)
  • Rituxan (rituximab)
  • Ruxience (rituximab-pvvr)
  • Truxima (rituximab-abbs)
Fertility Support
  • Fyremadel (ganirelix)
  • Brand ganirelix
  • Generic ganirelix
  • Generic cetrorelix
  • Cetrotide (cetrorelix)
Inflammatory Diseases
  • Hyrimoz (adalimumab-adaz)
  • Adalimumab-adaz
  • Adalimumab-adbm
  • Adalimumab-ryvk
  • Cyltezo (adalimumab-adbm)
  • Humira (adalimumab) (AbbVie)*
  • Simlandi (adalimumab-ryvk)
  • Avsola (infliximab-axxq)
  • Inflectra (infliximab-dyyb)
  • Brand Infliximab
  • Remicade (infliximab)
Rare Diseases
  • Glassia (alpha1-proteinase inhibitor)
  • Aralast (alpha1-proteinase inhibitor)
  • Prolastin-C (alpha1-proteinase inhibitor)
  • Zemaira (alpha1-proteinase inhibitor)
  • Remodulin (treprostinil)
  • Generic treprostinil
  • Rusting (rozanolixizumab-noli)
  • Soliris (eculizumab)
  • Ultomiris (ravulizumab-cwvz)
  • Vyvgart (efgartigimod alfa-fcab)
  • Vyvgart Hytrulo (efgartigimod-hyaluronidase-qvfc)

* Available for current users only.

New prescriptions: For prescriptions dispensed on or after January 2025, you will need to submit a prior authorization.

Existing prescriptions: If you determine a preferred alternative isn’t appropriate for a member already taking one of the prescriptions above, you will need to submit a prior authorization, and the member must meet all criteria. Members who receive an approved prior authorization may have higher out-of-pocket costs than a preferred alternative drug depending on their health plan.

Communication: If the member picked up the drug from a pharmacy, they were mailed a letter on November 1, 2024, encouraging them to contact their provider. We also notified you of the change in our October 2024 Provider News.

Contact: Call our pharmacy services team at 888-261-1756 if you have questions. Our pharmacy services team is available Monday through Friday from 7:30 a.m. to 6 p.m. Pacific Time.